COMPOUND FOR TARGETED PROTEIN DEGRADATION, AND USE THEREOF

Title:

COMPOUND FOR TARGETED PROTEIN DEGRADATION, AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2024/072178

Kind Code:

A1

Abstract:

The present invention relates to a compound for targeted protein degradation and a use thereof, and more specifically, the compound according to the present invention degrades epidermal growth factor receptor (EGFR) mutant proteins, and is thus useful for treating diseases, such as cancer, associated with EGFR mutations.

Inventors:

HAN WOOSEOK (KR)
NAM JOONWOO (KR)
KI DONG HYUK (KR)
KIM EUN-JUNG (KR)
CHOI HUN-MI (KR)
KIM CHULWON (KR)
KIM JIYEON (KR)

Application Number:

PCT/KR2023/015157

Publication Date:

April 04, 2024

Filing Date:

September 27, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CYRUS THERAPEUTICS INC (KR)
BRIDGE BIOTHERAPEUTICS INC (KR)

International Classes:

C07D401/14; A61K31/506; A61P35/00

Attorney, Agent or Firm:

RYU, Jong Woo et al. (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: ELECTRONIC DEVICE AND METHOD IN WHICH COMMAND TO DISPLAY IS CONTROLLED

Next Patent: SIGNAL TRANSMISSION/RECEPTION METHOD FOR WIRELESS COMMUNICATION, AND DEVICE THEREFOR